Kenneth J. Kelley, Director at HALOZYME THERAPEUTICS INC (HALO), sold 20,000 shares at $21.00 ($420K) on 2015-06-18, disclosed to the SEC on 2015-06-22.
Open-market sale of $420k HALO by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| HALO | SELL | 2021-02-01 | $469K | — | Filing → |
| HALO | SELL | 2021-01-04 | $417K | — | Filing → |
| HALO | SELL | 2020-12-07 | $1.4M | — | Filing → |